Leigh Shultz is currently Associate Vice President, Primary Care, Infectious Disease, and Vaccines in Global Project and Alliance Management (GPAM) in Merck Research Laboratories, with overall accountability for a team of senior leaders and project managers who deliver projects across the Diabetes, Women’s Health, Bone, Cardiovascular, Respiratory/Immunology, Neuroscience, Infectious Disease, and Vaccines therapeutic areas. Leigh has managed both early and late projects across multiple therapeutic areas in Merck’s primary care portfolio, including marketed products, and has experience with line management of both individual contributors and managers of people; prior to her current role, Leigh was the GPAM Therapeutic Area Lead for Diabetes and Endocrinology. Originally trained as a chemist, she holds a PhD in Inorganic Chemistry from the University of North Carolina at Chapel Hill and a Bachelors of Science in Chemistry from the University of Florida; she joined Merck in 2001 as a preformulation chemist in Pharmaceutical R&D. Leigh joined Merck’s Global Project Management department in 2004 and has held positions of increasing scope and responsibility since that time. She obtained her PMP certification in 2007.